Sunrun: BMO cuts target price to $7.75 from $10.50
RUN•BMO cut its target price for Sunrun to $7.75 from $10.50.
Related News
Enveric Biosciences reports positive preclinical study results for EB-003
ENVB•
Roche’s fenebrutinib cuts annualized MS relapse rate 55% versus comparator in Phase III trials
RHHBY•
a.k.a. Brands to report third-quarter financial results
AKA•
Abbott falls as it cuts 2026 sales growth view, plans to spin off nutrition business
ABT•
Axcelis Technologies publishes update to financial calendar
ACLS•